Angiotensin II Type 1 Receptor Gene Polymorphism in End-Stage Renal Disease

Publisher： Karger

E-ISSN： 2235-3186|92|1|51-55

ISSN： 1660-8151

Source： Nephron, Vol.92, Iss.1, 2002-08, pp. : 51-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II Type 1 Receptor Antagonist, Losartan, Causes Regression of Left Ventricular Hypertrophy in End-Stage Renal Disease

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 256-261

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors but Not Angiotensin II AT 1 Receptor Antagonists Affect Erythropoiesis in Patients with Anemia of End-Stage Renal Disease

By  

Nephron, Vol. 81, Iss. 1, 1999-01 ,pp. : 106-108

Karger

Access to resources Recommend Favorite

Polymorphism of the Angiotensin-Converting Enzyme Gene in End-Stage Renal Failure Patients

By  

Nephron, Vol. 85, Iss. 1, 2000-04 ,pp. : 54-59

Karger

Access to resources Recommend Favorite

High Accumulation of Endothelial Nitric Oxide Synthase (ecNOS):A Gene Polymorphism in Patients with End-Stage Renal Disease

By  

Nephron, Vol. 79, Iss. 3, 1998-06 ,pp. : 360-361

Karger

Access to resources Recommend Favorite

M235T Polymorphism in the AGT Gene and A/GI8-83 Substitution in the REN Gene Correlate with End-Stage Renal Disease

By  

Nephron, Vol. 129, Iss. 2, 2015-01 ,pp. : 104-108

Karger

Access to resources Recommend Favorite